| Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma (NCT04120649) | Assiut University | 2020-05-18 |
| Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer (NCT04453904) | Peking University People's Hospital | 2020-05-12 |
| Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors (NCT04344795) | Tempest Therapeutics | 2020-05-06 |
| Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study (NCT04214964) | Tongji Hospital | 2020-04-11 |
| 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer (NCT04227249) | Seoul National University Hospital | 2020-04-01 |
| Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health (NCT04000880) | University of Alabama at Birmingham | 2020-03-04 |
| Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function (NCT04295109) | The First Affiliated Hospital with Nanjing Medical University | 2020-03-02 |
| To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer (NCT04514289) | Haseki Training and Research Hospital | 2020-03-01 |
| Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma (NCT04743999) | Henry Ford Health System | 2020-02-27 |
| Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease (NCT04291612) | Memorial Sloan Kettering Cancer Center | 2020-02-26 |
| Effects of Centering Pre-operative Counseling on Patient Reported Anxiety (NCT04068675) | Northwestern University | 2020-02-24 |
| Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer (NCT03932409) | University of Oklahoma | 2020-02-19 |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel (NCT04237090) | Ciusss de L'Est de l'Île de Montréal | 2020-02-14 |
| Vibrational Spectroscopy for Endometrial Cancer Diagnosis (NCT05026073) | Nottingham University Hospitals NHS Trust | 2020-01-19 |
| Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer (NCT04235179) | King Saud University | 2020-01-16 |
| Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece (NCT04696276) | University of West Attica | 2020-01-06 |
| The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. (NCT04403867) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-02 |
| P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer (NCT05542940) | Hossam Hassan Aly Hassan El Sokkary | 2020-01-01 |
| FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment (NCT03489473) | Radboud University Medical Center | 2020-01-01 |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma (NCT04080284) | Northwell Health | 2019-12-30 |
| A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (NCT04188548) | Eli Lilly and Company | 2019-12-10 |
| The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study (NCT04122235) | Sorlandet Hospital HF | 2019-11-18 |
| Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer (NCT04157491) | Sun Yat-sen University | 2019-10-18 |
| TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer (NCT03955978) | Washington University School of Medicine | 2019-10-15 |
| Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. (NCT03983954) | NeoTX Therapeutics Ltd. | 2019-10-10 |
| High Intensity Interval Training in Endometrial Cancer (NCT04025229) | UNC Lineberger Comprehensive Cancer Center | 2019-09-23 |
| A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas (NCT04104776) | Novartis Pharmaceuticals | 2019-09-18 |
| Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. (NCT04021459) | University Hospital, Montpellier | 2019-09-16 |
| ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) (NCT04044859) | USWM CT, LLC | 2019-08-20 |
| CT Assessment of BMI in Endometrial Cancer Patients (NCT03962140) | Royal Cornwall Hospitals Trust | 2019-08-01 |
| The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (NCT03694262) | Medical College of Wisconsin | 2019-07-19 |
| Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies (NCT04149691) | Celon Pharma SA | 2019-07-19 |
| Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis (NCT04010487) | Lei Li | 2019-07-16 |
| Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers (NCT03595722) | Imperial College London | 2019-07-11 |
| Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS (NCT04866394) | Sunnybrook Health Sciences Centre | 2019-07-03 |
| The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons (NCT03538665) | University of Alabama at Birmingham | 2019-07-01 |
| Quality of Life After Robotic Surgery for Endometrial Cancer (NCT04281043) | Sahlgrenska University Hospital | 2019-06-15 |
| Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers (NCT04626895) | Medstar Health Research Institute | 2019-06-04 |
| Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer (NCT06732635) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2019-06-01 |
| Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction (NCT06096688) | Weill Medical College of Cornell University | 2019-05-29 |
| Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors (NCT03776630) | Assistance Publique - Hôpitaux de Paris | 2019-05-23 |
| Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome (NCT05257057) | WellSpan Health | 2019-05-08 |
| Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer (NCT03900104) | Kocaeli University | 2019-05-01 |
| Ketohexokinase Isoforms in Endometrial Cancer. (NCT03931265) | Far Eastern Memorial Hospital | 2019-04-11 |
| Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients (NCT04212377) | Radboud University Medical Center | 2019-04-08 |
| Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer (NCT03694834) | UNC Lineberger Comprehensive Cancer Center | 2019-03-29 |
| VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. (NCT03324958) | Centre Hospitalier Universitaire de Saint Etienne | 2019-03-26 |
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer (NCT03860272) | Agenus Inc. | 2019-03-20 |
| FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study (NCT03926936) | Frederic Amant | 2019-03-13 |
| Urinary miRNA in Endometrial Cancer Study (NCT03824613) | Royal Cornwall Hospitals Trust | 2019-03-08 |
| Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer (NCT03935256) | Loyola University | 2019-03-05 |
| the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer (NCT03908996) | Sanford Health | 2019-02-11 |
| Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? (NCT05448586) | Instituto de Investigación Hospital Universitario La Paz | 2019-02-02 |
| Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease (NCT03838055) | Region Skane | 2019-02-01 |
| Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers (NCT03748186) | Sutro Biopharma, Inc. | 2019-02-01 |
| Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors (NCT03827837) | Jiangsu HengRui Medicine Co., Ltd. | 2019-01-23 |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors (NCT03682289) | Rahul Aggarwal | 2019-01-17 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| Vaginal Cuff Brachytherapy Fractionation Study (NCT03785288) | Kara Romano, MD | 2019-01-17 |
| Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients (NCT06148129) | Zagazig University | 2019-01-12 |
| The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer (NCT03804463) | Min Wang | 2019-01-10 |
| RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer (NCT03675893) | Dana-Farber Cancer Institute | 2018-12-24 |
| Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (NCT03339843) | Jules Bordet Institute | 2018-12-19 |
| Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors (NCT03722030) | University of Wisconsin, Madison | 2018-12-05 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. (NCT03349463) | Bital Savir-Baruch | 2018-11-14 |
| MSI in Circulatory DNA of Endometrial Cancer (NCT03744962) | Lei Li | 2018-11-10 |
| Atezolizumab Trial in Endometrial Cancer - AtTEnd (NCT03603184) | Mario Negri Institute for Pharmacological Research | 2018-10-02 |
| Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma (NCT03553589) | Andrea Romano | 2018-10-01 |
| A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors (NCT03665285) | NextCure, Inc. | 2018-10-01 |
| MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback (NCT03820024) | UNC Lineberger Comprehensive Cancer Center | 2018-09-28 |
| An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis (NCT03876860) | Margaret Liotta | 2018-09-24 |
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. (NCT03667716) | Compugen Ltd | 2018-09-06 |
| 4FMFES-PET Imaging of Endometrial and Ovarian Cancers (NCT04823065) | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 2018-09-01 |
| Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer (NCT03526432) | University of Oklahoma | 2018-08-08 |
| Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer (NCT03611517) | Leiden University Medical Center | 2018-08-07 |
| A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies (NCT03629756) | Arcus Biosciences, Inc. | 2018-07-24 |
| Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer (NCT03567655) | Asan Medical Center | 2018-07-15 |
| Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer (NCT03115593) | Brugmann University Hospital | 2018-07-10 |
| Anxiety and Distress Levels in Women With Suspected Endometrial Cancer (NCT03813719) | Imperial College London | 2018-07-01 |
| POSE - POs Surgery Endometrial Cancer (NCT06394258) | Fundacao Champalimaud | 2018-06-18 |
| Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers (NCT03564340) | Regeneron Pharmaceuticals | 2018-05-21 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer (NCT03503786) | National Cancer Institute, Naples | 2018-04-01 |
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC (NCT03463252) | West China Second University Hospital | 2018-04-01 |
| Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer (NCT03466788) | Centre Francois Baclesse | 2018-03-29 |
| FPA150 in Patients With Advanced Solid Tumors (NCT03514121) | Five Prime Therapeutics, Inc. | 2018-03-27 |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma (NCT03395080) | Leap Therapeutics, Inc. | 2018-03-05 |
| A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients (NCT03285152) | Memorial Sloan Kettering Cancer Center | 2018-02-19 |
| The Role of Hypoxia as a Selective Pressure for TP53 Mutations (NCT03466034) | Institute of Cancer Research, United Kingdom | 2018-02-06 |
| ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma (NCT03394027) | National Cancer Institute (NCI) | 2018-01-17 |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] (NCT03555422) | Karyopharm Therapeutics Inc | 2018-01-05 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Sentinel Node Mapping in High Risk Endometrial Cancer (NCT03366051) | AC Camargo Cancer Center | 2017-12-22 |
| Human Epididymis Protein 4 in Endometrial Carcinoma (NCT03456791) | Ain Shams University | 2017-12-01 |
| HE4 is a Beneficial Biomarker in Endometrial Cancer (NCT03459976) | Ain Shams University | 2017-12-01 |
| A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors (NCT03314935) | Incyte Corporation | 2017-11-21 |
| Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer (NCT03016338) | University Health Network, Toronto | 2017-11-06 |
| Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing (NCT03322176) | Data Collection Analysis Business Management | 2017-10-17 |
| European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III (NCT04504006) | Dr. Paul Buderath | 2017-10-10 |